St George's Vascular Institute, St George's Healthcare NHS Trust, London, UK.
Department of Endocrinology, University Hospital of Malmö, Malmö, Sweden.
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:119-27. doi: 10.1002/dmrr.2703.
Non-invasive tests for the detection of peripheral artery disease (PAD) among individuals with diabetes mellitus are important to estimate the risk of amputation, ulceration, wound healing and the presence of cardiovascular disease, yet there are no consensus recommendations to support a particular diagnostic modality over another and to evaluate the performance of index non-invasive diagnostic tests against reference standard imaging techniques (magnetic resonance angiography, computed tomography angiography, digital subtraction angiography and colour duplex ultrasound) for the detection of PAD among patients with diabetes. Two reviewers independently screened potential studies for inclusion and extracted study data. Eligible studies evaluated an index test for PAD against a reference test. An assessment of methodological quality was performed using the quality assessment for diagnostic accuracy studies instrument. Of the 6629 studies identified, ten met the criteria for inclusion. In these studies, the patients had a median age of 60-74 years and a median duration of diabetes of 9-24 years. Two studies reported exclusively on patients with symptomatic (ulcerated/infected) feet, two on patients with asymptomatic (intact) feet only, and the remaining six on patients both with and without foot ulceration. Ankle brachial index (ABI) was the most widely assessed index test. Overall, the positive likelihood ratio and negative likelihood ratio (NLR) of an ABI threshold <0.9 ranged from 2 to 25 (median 8) and <0.1 to 0.7 (median 0.3), respectively. In patients with neuropathy, the NLR of the ABI was generally higher (two out of three studies), indicating poorer performance, and ranged between 0.3 and 0.5. A toe brachial index <0.75 was associated with a median positive likelihood ratio and NLRs of 3 and ≤ 0.1, respectively, and was less affected by neuropathy in one study. Also, in two separate studies, pulse oximetry used to measure the oxygen saturation of peripheral blood and Doppler wave form analyses had NLRs of 0.2 and <0.1. The reported performance of ABI for the diagnosis of PAD in patients with diabetes mellitus is variable and is adversely affected by the presence of neuropathy. Limited evidence suggests that toe brachial index, pulse oximetry and wave form analysis may be superior to ABI for diagnosing PAD in patients with neuropathy with and without foot ulcers. There were insufficient data to support the adoption of one particular diagnostic modality over another and no comparisons existed with clinical examination. The quality of studies evaluating diagnostic techniques for the detection of PAD in individuals with diabetes is poor. Improved compliance with guidelines for methodological quality is needed in future studies.
对于患有糖尿病的个体,外周动脉疾病(PAD)的非侵入性检测对于估计截肢、溃疡、伤口愈合和心血管疾病的风险很重要,但目前尚无共识建议支持特定的诊断方式优于另一种方式,也无法评估索引非侵入性诊断测试在检测糖尿病患者 PAD 方面相对于参考标准成像技术(磁共振血管造影、计算机断层血管造影、数字减影血管造影和彩色双功超声)的性能。两位审稿人独立筛选潜在的研究进行纳入并提取研究数据。合格的研究评估了 PAD 的索引测试与参考测试。使用诊断准确性研究工具评估方法学质量。在确定的 6629 项研究中,有 10 项符合纳入标准。在这些研究中,患者的中位年龄为 60-74 岁,糖尿病的中位病程为 9-24 年。有两项研究仅报道了有症状(溃疡/感染)足部的患者,两项研究仅报道了无症状(完整)足部的患者,其余六项研究报道了有和没有足部溃疡的患者。踝臂指数(ABI)是最广泛评估的索引测试。总体而言,ABI 阈值<0.9 的阳性似然比和阴性似然比(NLR)范围为 2 至 25(中位数 8)和<0.1 至 0.7(中位数 0.3)。在有神经病变的患者中,ABI 的 NLR 通常更高(三项研究中有两项),表明性能较差,范围在 0.3 至 0.5 之间。足趾臂指数<0.75 与中位阳性似然比和 NLRs 分别为 3 和≤0.1 相关,在一项研究中受神经病变的影响较小。此外,在两项单独的研究中,用于测量外周血液氧饱和度的脉搏血氧仪和多普勒波形态分析的 NLR 分别为 0.2 和<0.1。ABI 用于诊断糖尿病患者 PAD 的报告性能各不相同,并且受神经病变的影响。有限的证据表明,在有和没有足部溃疡的神经病变患者中,足趾臂指数、脉搏血氧仪和波形态分析可能优于 ABI 用于诊断 PAD。没有足够的数据支持采用一种特定的诊断方式而不是另一种方式,也没有与临床检查进行比较。评估糖尿病患者 PAD 检测诊断技术的研究质量较差。未来的研究需要提高对方法学质量指南的遵守。